PuSH - Publication Server of Helmholtz Zentrum München

Tan, J.* ; Wagner, M. ; Stenton, S. ; Strom, T.M. ; Wortmann, S.B. ; Prokisch, H. ; Meitinger, T. ; Oexle, K. ; Klopstock, T.*

Corrigendum to “Lifetime risk of autosomal recessive mitochondrial disorders calculated from genetic databases” [EBioMedicine 54 (2020) 102730] (EBioMedicine (2020) 54, (S2352396420301055), (10.1016/j.ebiom.2020.102730)).

EBioMedicine 61:103072 (2020)
Correction DOI
Creative Commons Lizenzvertrag
Open Access Gold as soon as Publ. Version/Full Text is submitted to ZB.
The authors regret that the published manuscript contains a few rounding and copying errors. The mistakes are minor but affect the allele frequencies of disease-causing variants in 3 genes. These minor corrections do not change the overall description, interpretation, or conclusions of the manuscript. page 4, paragraph 3.1., 2nd sentence: The sum of their allele frequencies was 0.0111 in the European (Non-Finnish) and 0.0091 in the total gnomAD dataset resulting in a calculated PKU lifetime risk of 16.0 (14.5–17.6 95% CI)/100,000 in the European (Non-Finnish) population and of 8.2 (7.6–8.9)/100,000 in the total dataset. is corrected to The sum of their allele frequencies was 0.0126 in the European (Non-Finnish) and 0.0091 in the total gnomAD dataset resulting in a calculated PKU lifetime risk of 16.0 (14.5–17.6 95% CI)/100,000 in the European (Non-Finnish) population and of 8.2 (7.6–8.9)/100,000 in the total dataset. page 4, paragraph 3.2., close to the end of 3rd paragraph The allele frequency of POLG mutations was 0.0083 in the European (Non-Finnish) gnomAD dataset, 0.0061 in the total gnomAD dataset and 0.0074 in the in-house database, resulting in lifetime risk estimates for POLG-associated disorders of 6.9 (6.1–7.8), 3.7 (3.4–4.0) and 3.7 (3.3–4.1)/100,000, respectively. is corrected to The allele frequency of POLG mutations was 0.0083 in the European (Non-Finnish) gnomAD dataset, 0.0061 in the total gnomAD dataset and 0.0061 in the in-house database, resulting in lifetime risk estimates for POLG-associated disorders of 6.9 (6.1–7.8), 3.7 (3.4–4.0) and 3.7 (3.3–4.1)/100,000, respectively. page 6, right column, line 4–6 Implying a combined frequency of 0.0083, and leading to a calculated MCADD lifetime risk of 4.8 (3.6–6.3)/100,000. is corrected to Implying a combined frequency of 0.0069, and leading to a calculated MCADD lifetime risk of 4.8 (3.6–6.3)/100,000. In addition, the Author Contribution section was accidentally omitted due to a production error. This reads: MW and TK conceived the study. JT and MW defined a comprehensive list of mitochondrial disease genes and set up a list of pathogenic variants in these genes, supported by SLS, TMS, and SBW. JT and MW queried two databases (gnomAD and in house) to assess the allele frequencies of disease-causing variants in the general population and calculated the lifetime risks, supported by HP, TM, KO and TK. JT and MW drafted the manuscript which was then refined by all other authors and finalized by MW and TK.
Altmetric
Additional Metrics?
[➜Log in]
Edit extra informations Login
Publication type Other: Correction, Addition
Corresponding Author
ISSN (print) / ISBN 2352-3964
e-ISSN 2352-3964
Journal EBioMedicine
Quellenangaben Volume: 61, Issue: , Pages: , Article Number: 103072 Supplement: ,
Publisher Elsevier
Publishing Place Amsterdam [u.a.]
Non-patent literature Publications
Reviewing status Peer reviewed
Institute(s) Institute of Neurogenomics (ING)
Institute of Human Genetics (IHG)